QA: Harrow INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001360214_2026_Harrow_INC.pdf

Logs

Graph

Absolute values for 0001360214, Harrow INC

  xvar xval
0 AssetsCurrent 211,750,000
1 IntangibleAssetsNetIncludingGoodwill 175,506,000
2 PropertyPlantAndEquipmentNet 3,260,000
3 remainder_Assets 8,966,000
4 LiabilitiesCurrent 96,302,000
5 LiabilitiesNoncurrent 7,905,000
6 remainder_Liabilities 243,184,000
7 CostOfGoodsAndServicesSold 103,728,826
8 SellingGeneralAndAdministrativeExpense 233,157,127
9 ResearchAndDevelopmentExpense 19,685,324
10 remainder_Expenses 3,512,886
11 remainder_Revenues 635,482,409
12 remainder_NetIncome -30,698,953
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 399,482,000
1 Liabilities 347,391,000
2 Expenses 360,084,163
3 Revenues 635,482,409
4 StockholdersEquity 52,091,000
5 NetIncome 244,699,293
6 ComprehensiveNetIncome 244,699,293
7 BaseVar 886,569,262
8 EconomicCapitalRatiobeforeLimitedLiability 0.959
9 EconomicCapitalRatio 2.27

Edgar->Model Mapping

Feature Distribution

Change over Time